[144] AGCO Corporation SEC Filing

Rhea-AI Filing Summary

The filer notifies a proposed sale of 5,000 shares of common stock of AGCO through Fidelity Brokerage, with an aggregate market value of $557,500.00 and an approximate sale date of 08/08/2025 to be executed on the NYSE. The filing reports 74,620,227 shares outstanding.

The securities were acquired by restricted stock vesting: 2,218 shares on 01/22/2023 and 2,782 shares on 02/07/2025, with payment described as compensation. The filer reports no securities sold in the past three months and makes the required representation that they do not possess undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Insider filed to sell 5,000 AGCO shares worth $557,500; transaction appears immaterial to shareholders.

The Form 144 discloses a proposed sale of 5,000 shares via Fidelity with an aggregate market value of $557,500.00 and an approximate sale date of 08/08/2025. The securities originate from restricted stock vesting, indicating they were issued as compensation. The filing also reports no sales in the past three months. Given the reported outstanding share count of 74,620,227, the sale represents a very small portion of the capital base, suggesting limited market impact.

Corporate Governance Expert

TL;DR: Transaction stems from vested compensation and is disclosed via standard Form 144; filer affirms no undisclosed material adverse information.

The notice shows two vesting events—01/22/2023 for 2,218 shares and 02/07/2025 for 2,782—both described as compensation. The filer signs the representation required by the form regarding material adverse information and reports no prior sales in the past three months. This is a routine insider disclosure consistent with compliance and governance procedures rather than an indicator of corporate distress or major governance change.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5000	557500.00	74620227	08/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/22/2023	Restricted Stock Vesting	Issuer			2218	01/22/2023	Compensation
Common	02/07/2025	Restricted Stock Vesting	Issuer			2782	02/07/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AGCO's Form 144 disclose?

The notice discloses a proposed sale of 5,000 common shares via Fidelity, aggregate value $557,500.00, approximate sale date 08/08/2025, and 74,620,227 shares outstanding.

How many AGCO shares is the insider proposing to sell?

The filer proposes to sell 5,000 shares of AGCO common stock.

When is the proposed AGCO sale scheduled and on which exchange?

The approximate sale date is 08/08/2025 and the sale is to be executed on the NYSE.

How were the shares being sold acquired?

The shares were acquired by restricted stock vesting: 2,218 shares on 01/22/2023 and 2,782 shares on 02/07/2025, recorded as compensation.

Has the filer sold any AGCO securities in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.